1933 Industries Reports Second Quarter 2025 Financial Results
1933 Industries (OTC PINK:TGIFF) reported its Q2 2025 financial results, showing revenue of $4.4 million, an 11% increase from Q1 2025. The company achieved a gross profit of $1.5 million with a 35% gross margin, up from 30% in Q2 2024. The net loss narrowed to $0.3 million, improving from $0.6 million in Q2 2024.
The company's Alternative Medicine Association (AMA) maintained its second place ranking in Nevada's flower category. Total revenues for Fiscal 2025 reached $8.4 million, down from $9.8 million in Fiscal 2024, attributed to slower Q1 2025 retail sales. Operating expenses decreased to $1.8 million from $2.0 million year-over-year, primarily due to reduced wages and benefits.
1933 Industries (OTC PINK:TGIFF) ha riportato i risultati finanziari per il secondo trimestre del 2025, evidenziando un fatturato di 4,4 milioni di dollari, con un aumento dell'11% rispetto al primo trimestre del 2025. L'azienda ha realizzato un utile lordo di 1,5 milioni di dollari con un margine lordo del 35%, in crescita rispetto al 30% del secondo trimestre del 2024. La perdita netta si è ridotta a 0,3 milioni di dollari, migliorando rispetto ai 0,6 milioni di dollari del secondo trimestre del 2024.
L'Associazione per la Medicina Alternativa (AMA) dell'azienda ha mantenuto il secondo posto nella categoria dei fiori in Nevada. I ricavi totali per l'anno fiscale 2025 hanno raggiunto 8,4 milioni di dollari, in calo rispetto ai 9,8 milioni di dollari dell'anno fiscale 2024, attribuibile a vendite al dettaglio più lente nel primo trimestre del 2025. Le spese operative sono diminuite a 1,8 milioni di dollari rispetto ai 2,0 milioni di dollari dell'anno precedente, principalmente a causa della riduzione di salari e benefici.
1933 Industries (OTC PINK:TGIFF) reportó sus resultados financieros del segundo trimestre de 2025, mostrando ingresos de 4.4 millones de dólares, un incremento del 11% respecto al primer trimestre de 2025. La compañía logró un beneficio bruto de 1.5 millones de dólares con un margen bruto del 35%, por encima del 30% en el segundo trimestre de 2024. La pérdida neta se redujo a 0.3 millones de dólares, mejorando desde los 0.6 millones de dólares en el segundo trimestre de 2024.
La Asociación de Medicina Alternativa (AMA) de la compañía mantuvo su segundo lugar en la categoría de flores de Nevada. Los ingresos totales para el año fiscal 2025 alcanzaron 8.4 millones de dólares, una disminución desde los 9.8 millones de dólares en el año fiscal 2024, atribuida a ventas minoristas más lentas en el primer trimestre de 2025. Los gastos operativos disminuyeron a 1.8 millones de dólares desde 2.0 millones de dólares en el año anterior, principalmente debido a la reducción de salarios y beneficios.
1933 Industries (OTC PINK:TGIFF)는 2025년 2분기 재무 결과를 발표하며 440만 달러의 수익을 기록했으며, 이는 2025년 1분기 대비 11% 증가한 수치입니다. 회사는 35%의 총 이익률로 150만 달러의 총 이익을 달성했으며, 이는 2024년 2분기의 30%에서 증가한 것입니다. 순손실은 30만 달러로 축소되어 2024년 2분기의 60만 달러에서 개선되었습니다.
회사의 대체 의학 협회(AMA)는 네바다의 꽃 카테고리에서 2위를 유지했습니다. 2025 회계연도의 총 수익은 840만 달러에 달했으며, 이는 2024 회계연도의 980만 달러에서 감소한 수치로, 2025년 1분기 소매 판매의 둔화에 기인합니다. 운영 비용은 전년 대비 200만 달러에서 180만 달러로 감소했으며, 주로 임금 및 복리후생의 축소로 인한 것입니다.
1933 Industries (OTC PINK:TGIFF) a annoncé ses résultats financiers pour le deuxième trimestre 2025, affichant un chiffre d'affaires de 4,4 millions de dollars, soit une augmentation de 11 % par rapport au premier trimestre 2025. L'entreprise a réalisé un bénéfice brut de 1,5 million de dollars avec une marge brute de 35 %, en hausse par rapport à 30 % au deuxième trimestre 2024. La perte nette s'est réduite à 0,3 million de dollars, s'améliorant par rapport à 0,6 million de dollars au deuxième trimestre 2024.
L'Association de Médecine Alternative (AMA) de l'entreprise a maintenu sa deuxième place dans la catégorie des fleurs du Nevada. Les revenus totaux pour l'exercice fiscal 2025 ont atteint 8,4 millions de dollars, en baisse par rapport à 9,8 millions de dollars pour l'exercice fiscal 2024, attribuée à des ventes au détail plus lentes au premier trimestre 2025. Les dépenses d'exploitation ont diminué à 1,8 million de dollars contre 2,0 millions de dollars l'année précédente, principalement en raison de la réduction des salaires et des avantages sociaux.
1933 Industries (OTC PINK:TGIFF) berichtete über die finanziellen Ergebnisse für das zweite Quartal 2025 und wies einen Umsatz von 4,4 Millionen Dollar aus, was einem Anstieg von 11% im Vergleich zum ersten Quartal 2025 entspricht. Das Unternehmen erzielte einen Bruttogewinn von 1,5 Millionen Dollar mit einer Bruttomarge von 35%, die im Vergleich zu 30% im zweiten Quartal 2024 gestiegen ist. Der Nettoverlust verringerte sich auf 0,3 Millionen Dollar, was eine Verbesserung gegenüber 0,6 Millionen Dollar im zweiten Quartal 2024 darstellt.
Die Alternative Medizin Vereinigung (AMA) des Unternehmens hielt ihren zweiten Platz in der Blumen-Kategorie in Nevada. Die Gesamterlöse für das Geschäftsjahr 2025 erreichten 8,4 Millionen Dollar, ein Rückgang von 9,8 Millionen Dollar im Geschäftsjahr 2024, was auf langsamere Einzelhandelsverkäufe im ersten Quartal 2025 zurückzuführen ist. Die Betriebskosten sanken auf 1,8 Millionen Dollar von 2,0 Millionen Dollar im Vorjahr, hauptsächlich aufgrund von reduzierten Löhnen und Sozialleistungen.
- 11% revenue increase quarter-over-quarter to $4.4M in Q2 2025
- Gross margin improved to 35% from 30% year-over-year
- Net loss reduced by 50% to $0.3M from $0.6M year-over-year
- Operating expenses decreased by 10% to $1.8M
- Maintained second place ranking in Nevada flower category
- Fiscal 2025 revenue declined to $8.4M from $9.8M year-over-year
- Continued net loss of $0.3M in Q2 2025
- Slower retail sales in Nevada during Q1 2025
VANCOUVER, BC / ACCESS Newswire / March 31, 2025 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF(OTC PINK:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce its second quarter financial results ("Q2 2025") for the three and six months ended January 31, 2025 and 2024 ("Fiscal 2025"). All amounts expressed are in Canadian dollars.
The Company owns
Q2 2025 Highlights
Revenue of
$4.4 million Gross profit of
$1.5 million Gross margin of
35% Net loss of
$0.3 million 2 nd place ranking in the Nevada flower category
FISCAL 2025 AND FISCAL 2024 CONSOLIDATED OPERATING FINANCIAL HIGHLIGHTS
Revenue
During Q2 2025, the Company recorded revenues of
$4.4 million , an11% increase over Q1 2025, reflecting an uptick in the Nevada cannabis market and demonstrating the strength of the AMA brand and its position as one of the top 5 selling brands in the state. Total revenues for Fiscal 2025 were$8.4 million and$9.8 million for Fiscal 2024. The decrease is attributed to slower retail sales in Nevada during Q1 2025.
Gross Profit
The Company generated gross profit of
$1.5 million in the current period compared to gross profit of$1.4 million in the prior year comparable period. Gross profit was$2.8 million for Fiscal 2025 and gross profit of$3.0 million for Fiscal 2024. The decrease in gross profit was primarily due to slower sales in Q1 2025.
Gross Margin
Gross margin calculated as gross profit divided by revenue was
35% in Q2 2025 and30% in Q2 2024 and34% in Fiscal 2025 and31% in Fiscal 2024. The increase is attributed to operational efficiencies in cultivation and production.
Expenses
During the reporting period, expenses decreased to
$1.8 million from$2.0 million in the prior year comparable period. Expenses were$3.7 million for Fiscal 2025 compared to$4.0 million for Fiscal 2024. The decrease from the prior year was primarily due to reduced wages and benefits.
Net Loss
Net loss for Q2 2025 was
$0.3 million compared to$0.6 million in Q2 2024. Company-wide, Fiscal 2025 net loss was$0.89 million and comprehensive loss was$0.7 million , compared to Fiscal 2024 net loss of$1.0 million and comprehensive loss of$0.6 million in the prior year comparable period.
Management Commentary
Overall, Nevada cannabis retail sales rebounded from the previous quarter, reflecting higher top line sales. AMA flower and pre-rolls gained market share and growth over the reporting period, ranking second as one of the most sold brands by volume. [1] AMA's solid position in the market highlights its ability to gain shelf space in dispensaries across the state and demonstrates increased consumer preference due to its consistent quality and value. AMA's ranking in the cannabis flower and concentrates category remains robust where it has maintained its second position, despite declining flower pricing and market contraction.
Financial statements are prepared in accordance with IFRS® Accounting Standards issued by the International Accounting Standards Board ("IASB") and the IFRIC® Interpretations of the IFRS Interpretations Committee. Detailed information regarding the Company's financial results as well as management's discussion and analysis can be found at https://sedar.com/ and https://1933industries.com/investors/financial-information
About 1933 Industries Inc.
1933 Industries is a Nevada-based licensed producer, focused on the cultivation and extraction of a large portfolio of cannabis consumer products in a variety of formats under its flagship brands, Alternative Medicine Association (AMA) and Level X. Its product offerings are cultivated at the Company's 68,000 sq. ft. indoor facility and marketed directly to retail dispensaries. AMA branded flower, infused pre-rolls, and in-house boutique concentrates consistently rank as the top products sold in Nevada. For more information, please visit www.1933industries.com
For further information please contact:
Alexia Helgason, VP, Investor Relations
604-728-4407
alexia@1933industries.com
Brian Farrell, Chairman and CEO
brian@1933industries.com
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Notice regarding Forward Looking Statements: This news release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents, which can be found under the Company's profile on www.sedar.com . 1933 Industries undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.
[1] https://www.headset.io/brands/alternative-medicine-association-ama
SOURCE: 1933 Industries Inc.
View the original press release on ACCESS Newswire
FAQ
What was TGIFF's revenue and profit margin in Q2 2025?
How did TGIFF's Q2 2025 net loss compare to the previous year?
What is TGIFF's market position in Nevada's cannabis market?
How did TGIFF's fiscal 2025 revenue compare to 2024?
What operational improvements did TGIFF achieve in Q2 2025?
